AGER and Hyperglycemia: A decrease in flRAGE levels was observed in patients with impaired glucose tolerance and also diabetes, which was probably due to hyperglycemia-induced augmented proteolytic degradation of the RAGE subdomain mediated by disintegrins and metalloproteinases10.